Comparable to the 2020 resolution, Novartis AG’s $twenty five million 2016 civil resolution Using the SEC anxious inappropriate sponsorships of HCPs to conferences and poor payments to HCPs to collect “health care information.” The truth that Novartis is currently struggling with a substantially larger sized—and felony—resolution for iden